Get Ready for Our HUGE New Breakout Play Coming Wednesday 4PM! Dear Fellow Trader, I Suggest You Fasten Your Seat Belt Now! Following the tremendous success of our recent big picks like ECRY which rocketed to a high of $0.569 today for massive gains of 118% from my alert and DEQI which I alerted you on December 4th and it ran up +86% on record breaking volume, we have made it our mission to uncover an even BIGGER opportunity for our readers and keep the momentum rolling!! Our team has come through once again in a major way! We have been in deep research mode scanning the markets looking for our next potential winner.
We believe, that we`ve found the next potential breakout play that could join our recent list of big winners! I will be releasing it tomorrow Wednesday the 10th at 4PM EST! So be sure and watch for my emails.
Here`s What You Must Do Next to Get My New Breakout Play Scheduled for Wednesday the 10th at 4PM EST! **You Must Reply Back to This Email if (YOU) Want My New Breakout Play**
» Step 1: Reply back to this Email Immediately! » Step 2: The subject line must be (Want New – Breakout Play!) By taking these two actions steps you will be locked in to get my next pick scheduled to hit your inbox (tomorrow) Wednesday the 10th at 4PM EST! Be Ready!! And remember, I ONLY will deliver this pick to those who take the action to request it. Do NOT hesitate, Reply Back Now!! Important reminder: Some readers sat on the sidelines doubting me on some of our recent big picks. As you can clearly see, they (missed the boat) and it hurt bad…
Missing out on any of our picks could be the (worst) decision you make.
Are you paying attention yet Remember, those who drag their feet will regret it! Don`t make me say I told you so…
YOU” Would Be Absolutely Insane Not to Clean Your Plates and Be Ready for Our New Breakout Play Coming (tomorrow) Wednesday the 10th at 4PM EST! ….So be on High Alert and Ready to Act! Stay Tuned! Happy Trading! The OTCtipReporter Team PS. My Incredible Winning Streak Set to Continue! We are Coming off of 45 huge winners that gained a combined total of 14,424% Gains since Jan 1rst! PPS. To make sure you take full advantage of our Newsletter make sure you add our email address: firstname.lastname@example.org to your email program`s safe sender list to ensure that you receive our Newsletter! This will ensure our emails don`t end up in the spam box.
100% TRANSPARENCY!!!! I am going to be extremely clear with you on how my newsletter works.
I DON`T FRONTLOAD, BUY or RECEIVE any SHARES of a Company that I Profile!! I NEVER OWN ANY POSITION IN A COMPANY I ALERT/PROFILE!! It would be UNFAIR, WRONG and ILLEGAL for me to have a position in ANY Company I ever Profile on my Newsletter! I just wanted to address this for some people who might think or wonder if I trade the companies I profile on my Newsletter or if I own a position before or during the time I profile them. The 100% honest truth is I DO NOT!!….. I do get CASH compensation to profile companies time to time.
DON`T MISS ANOTHER HOT OPPORTUNITY TO MAKE HUGE PROFITS! GENERAL NOTICE AND DISCLAIMER – PLEASE READ CAREFULLY The companies that are discussed on OTCtipReporter have not approved the statements made. This opinion contains forward-looking statements that involve risks and uncertainties. A company`s actual _results could differ materially from those described in any forward-looking statements or announcements discussed herein. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to _buy or sell securities. OTCtipReporter is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Nor are any of its officers, affiliates, or employees. Please consult a broker before _purchasing or selling any securities viewed on OTCtipReporter or mentioned herein. Affiliates, officers, directors and employees of OTCtipReporter may have also _b o u g h t or may _b u y shares of companies mentioned herein and may profit in the event those shares rise in value. OTCtipReporter wi ll not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make their own decision based on his or her judgment of the market. This advertisement is not a solicitation or recommendation to _b u y, sell or hold securities and does not provide an analysis of the financial position of the company. We recommend you use the information found in this advertisement as an initial starting point for conducting your own research on the advertised company in order to determine your own personal opinion of the company before investing. All statements and opinions contained in this advertisement are the sole opinion of the authors and are subject to change without notice. We are not _liable for any investment decisions by our readers. Readers should independently investigate and fully understand all risks before investing. It is strongly recommended that any _purchase or sale decision be discussed with a financial adviser or broker prior to completing any such _purchase or sale decision. We are not registered investment advisers, or broker-dealers, or members of any financial regulatory bodies. Furthermore, our associates and/or employees and/or principals may have stock positions in advertised companies purchased in the open market or in _private transactions. These positions may be liquidated, without prior notification, even after we have made positive comments regarding the advertised company. The receipt of this information constitutes your acceptance of these terms and conditions.
Reading this advertisement shall not create under any circumstances an offer to _b u y or sell stock in any company advertised. Nor shall it create any principal-agent relationship between the reader and us. Void where prohibited. Information within this advertisement contains “forward looking” statements within the meaning of _Section-27(a) of the U.S.
Securities_ _Act-of-1933_ and _Section _21(e) of t he U.S. _Securities _Exchange _Act-of -934. Neither OTCtipReporter, its officers, affiliates, or employees is a broker-dealer. The information on OTCtipReporter, including the opinions expressed and the statements made within, is for informational and advertising purposes only and should not be construed as investment-advice, and does not constitute an offer to sell any securities, nor is it to be construed as a solicitation to _purchase any securities in any state or other jurisdiction where the offer or sale is not permitted.
The information to prepare this report is believed to be from reliable sources, but no representation is made as to the accuracy or completeness of such information. Investment in securities carries a high degree of risk and involves risks and uncertainties, which may _result in investors losing all of their invested capital. Past performance does not _guarantee future results. The information contained herein contains “forward-looking _statements,” within the meaning of _Section-27A_ of the Securities Act-of-1933 and Section_ _21E of the Securities Exchange _Act-of-1934.
Forward-looking statements are based upon expectations, estimates and projections at the time the statements are made and involve risks and uncertainties that could cause actual events to differ materially from those anticipated. Forward-looking statements may be identified through the use of words such as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should, or might occur.
Any statements that express or involve predictions, expectations, beliefs, plans, projections, objectives, goals or future events or performance may be forward-looking statements. Factors that could cause actual results to differ materially include but are not limited to adverse economic conditions, intense _competition, lack of meaningful research _results, inadequate capital, termination of contracts or agreements, adv erse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other key personnel, and other risks detailed in the reports filed with the Securities and Exchange Commission by the companies who are mentioned in this periodical. Readers should consult with their own professional investment, tax and portfolio advisors before making any investment decision and should independently verify all information herein. More complete information about any of the companies mentioned in this periodical is available from the website of the Securities and Exchange Commission, at sec.gov, and copies of their filings may be read without charge and copies obtained at prescribed rates from the public reference facilities of the Commission, at 450 Fifth Street, NW, Washington, DC 20549.
Buying_ and Selling of Shares OTCtipReporter intends to sell its shares. OTCtipReporter may sell its shares for less than target prices given in opinions. OTCtipReporter affiliates, officers, directors and employees may have also _b o u g h t or may _b u y the shares discussed in this report and may profit in the event those shares rise in value. OTCtipReporter will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. There are risks involved Always remember that OTCtipReporter are not analysts and investing in securities such as the ones listed within are for high risk tolerant individuals only and not the general public. Whether you are an experienced investor or not you should always consult with a broker before _purchasing or selling any securities viewed on OTCtipReporter. If at any time you wish to be removed from our list simply